WELL Health Technologies (TSE:WEL) Earns Hold Rating from Desjardins

WELL Health Technologies (TSE:WELGet Rating)‘s stock had its “hold” rating reaffirmed by equities research analysts at Desjardins in a research report issued on Sunday, Zacks.com reports. Desjardins also issued estimates for WELL Health Technologies’ FY2022 earnings at $0.21 EPS and FY2023 earnings at $0.32 EPS.

WELL Health Technologies (TSE:WELGet Rating) last announced its quarterly earnings results on Thursday, March 31st. The company reported C$0.02 EPS for the quarter, topping analysts’ consensus estimates of C($0.02) by C$0.04. The company had revenue of C$115.68 million during the quarter.

Read More

Receive News & Ratings for WELL Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WELL Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.